R&D
Does drug development deliver on its promises?
October 24, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D
I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …
UK research cannot rest on its laurels, warns ABPI
October 21, 2011Medical Communications, Research and Development ABPI, NHS, R&D
The ABPI has warned that the UK must continue to attract investment for research, or risk being superseded by emerging …
Betting big on research in China
September 13, 2011Manufacturing and Production, Research and Development China, R&D
For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …
‘This R&D Malarkey, it’s broken, isn’t it?’
March 9, 2011Research and Development R&D, Sandwich, research productivity
Pharmaceutical industry leaders are increasingly admitting that the very low productivity of its R&D pipelines is unsustainable – but no …
Lilly hails progress of new R&D approaches
February 16, 2011Research and Development, Sales and Marketing Chorus, Mirror Portfolio, R&D, lilly
Lilly says two of its experimental approaches to re-designing R&D are beginning to pay off.Like all of its peers, the …
R&D productivity worse than previously reported
February 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing BIO, BMT, FDA, R&D
A new analysis of pharma’s R&D pipelines suggests the overall success rate for drugs moving from clinical trials to FDA …
Pfizer to close UK R&D site
February 1, 2011Research and Development Kent, Pfizer, R&D, Sandwich, closure
Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …
Drug development: where’s the added investment value?
February 18, 2010Research and Development CRO, Les Rose, R&D, biotech, funding
Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …
Get the best from your R&D team
December 6, 2006Business Services, Research and Development R&D, recruitment
One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …
R&D Scoreboard poor gauge of pharma investment in the UK
November 8, 2005Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard
The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
Pharma continues to invest in UK research and development
October 24, 2005Sales and Marketing Pfizer, R&D
UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …
Commercial and R&D: reinventing the relationship
October 17, 2003Research and Development R&D, commercial
Traditionally, pharma companies have been run as research-based organisations relying on well-integrated internal R&D capabilities to feed their commercial pipelines …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
